Compare Organon Pharma Indonesia Tbk. (SCPI) vs Gaya Abadi Sempurna Tbk. (SLIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Gaya Abadi Sempurna Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Gaya Abadi Sempurna Tbk. trades at Rp86 (market cap 211.85B, 17.12M 24h volume). The key difference: Gaya Abadi Sempurna Tbk. is far larger — about 2× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | SLIS | |
|---|---|---|
Market Cap | 104.4B | 211.85B |
Volume | — | 17.12M |
Lot | — | 171.25K |
Turnover | — | 1.44B |
Average Price | — | 84.25 |
Value | — | 1.44B |
Indicative Equilibrium Price | — | 86 |
Indicative Equilibrium Volume | — | 7.69K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Gaya Abadi Sempurna Tbk.
PT Gaya Abadi Sempurna Tbk. (The Company) was established based on Notarial Deed Soekaimi S.H., No. 155 dated September 26, 1996, Notary in Jakarta. The company have began its commercial operations since 1996.The Company’s holding entity and ultimate holding entity as of April 30, 2019 is PT Selis Investama Indonesia
Read more on SLIS →
